The overall trend of insiders is illustrated in the chart below:
AbbVie Inc. (NYSE:ABBV): Director Frederick H. Waddell Bought 2,000 Shares
Director of AbbVie Inc., Frederick H. Waddell, bought 2,000 shares on 2/04/2013 at an average price of $36.22. AbbVie Inc. has a market cap of $57.28 billion; its shares were traded at around $36.22 with and P/S ratio of 3.1756. The dividend yield of AbbVie Inc. stocks is 1.1%.
On Jan. 30, AbbVie confirmed it delivered strong sales growth with its marketed pharmaceutical products in 2012. The proprietary pharmaceutical segment of Abbott, representing the majority of AbbVie's revenue, grew more than 8 percent globally on an operational basis, excluding a nearly 3 percent negative impact from foreign exchange.
Abbott Laboratories (NYSE:ABT): Director William A. Osborn Bought 15,000 Shares
Director of Abbott Laboratories, William A. Osborn, bought 15,000 shares during the past week at an average price of $34.42. Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott Laboratories has a market cap of $54.39 billion; its shares were traded at around $34.42 with a P/E ratio of 8.3682 and P/S ratio of 1.386. The dividend yield of Abbott Laboratories stocks is 4.85%. Abbott Laboratories had an annual average earnings growth of 8.9% over the past 10 years. GuruFocus rated Abbott Laboratories the business predictability rank of 3-star.
On Jan. 23, Abbott announced financial results for the fourth quarter ended Dec. 31, 2012. Fourth-quarter diluted earnings per share, excluding specified items, were $1.51. Diluted earnings per share under Generally Accepted Accounting Principles (GAAP) were $0.66, including specified items. Full-year diluted earnings per share, excluding specified items, were $5.07, exceeding Abbott’s initial guidance range. Diluted earnings per share under GAAP were $3.72, including specified items.
Last week, Director William A. Osborn bought 10,000 shares of ABT stock. Senior Vice President Stephen R. Fussell sold 9,690 shares this month. Executive Vice President Laura J. Schumacher and Senior Vice President A. David Forrest sold shares in December, and Chairman and CEO Miles D. White sold shares in November.
Yum! Brands Inc. (NYSE:YUM): Director Robert D. Walter Bought 35,000 Shares
Director of Yum! Brands Inc., Robert D. Walter, bought 35,000 shares on 2/06/2013 at an average price of $65.37. Yum! Brands Inc. was incorporated under the laws of the state of North Carolina in 1997. Yum! Brands Inc. has a market cap of $29.5 billion; its shares were traded at around $65.37 with a P/E ratio of 19.2308 and P/S ratio of 2.2857. The dividend yield of Yum! Brands Inc. stocks is 1.9%. Yum Brands Inc. had an annual average earnings growth of 10.3% over the past 10 years.
On Feb. 4, Yum! Brands Inc. reported results for the fourth quarter ended Dec. 29, 2012 including EPS of $0.83, excluding Special Items. Reported EPS was $0.72 for the quarter and $3.38 for the year.
Last week, Director Robert D. Walter bought 35,000 shares of YUM stock. Senior Vice President and Chief Public Affairs Jonathan David Blum sold 3,242 shares this month. Senior Vice President and Chief Public Affairs Jonathan David Blum sold 3,244 shares in January. Director Massimo Ferragamo, Chief People Officer Hollan Anne Byerlein, Chair and CEO China Division Jingshyh S. Su and Senior Vice President Finance and CFO Richard Carucci sold shares in December.
Aetna Inc. (NYSE:AET): Executive Vice President, Local/Regional Bus Karen Rohan Bought 4,035 Shares
Executive Vice President, Local/Regional Bus of Aetna Inc., Karen Rohan, bought 4,035 shares on 02/06/2013 at an average price of $50.56. Aetna Inc. was incorporated in Pennsylvania in 1982 under the name of United States Health Care Systems Inc. Aetna Inc. has a market cap of $16.93 billion; its shares were traded at around $50.56 with a P/E ratio of 9.6712 and P/S ratio of 0.5052. The dividend yield of Aetna Inc. stocks is 1.43%. Aetna Inc. had an annual average earnings growth of 22.7% over the past 10 years. GuruFocus rated Aetna Inc. the business predictability rank of 2-star.
On Jan. 31, Aetna announced fourth-quarter 2012 operating earnings of $317.0 million, or $.94 per share. Full-year 2012 operating earnings were $1.77 billion, or $5.13 per share. Net income for the fourth quarter of 2012 was $190.1 million, or $.56 per share, and includes $.44 per share of charges for other items, primarily a litigation-related settlement, offset by $.06 per share of net realized capital gains. Full-year net income was $1.66 billion, or $4.81 per share.
Last week, Executive Vice President, Local/Regional Business Karen Rohan bought 4,035 shares of AET stock. Director Molly Joel Coye, Director Edward J. Ludwig, Senior Vice President and General Counsel William James Casazza, Vice President, Controller and Chief Accounting Officer Rajan Parmeswar, and Chairman, CEO and President Mark T. Bertolini sold shares in December.
For the complete list of stocks that were bought by their company executives, go to: Insider Buys.